Dangerous Prescription Drugs

FDA Warns of Heart Problems and Cancer with Arthritis Drug Xeljanz

The arthritis and ulcerative colitis drug Xeljanz (tofacitinib) could potentially increase the risk of heart-related problems and cancer, according to a February 2021…

Michelle Llamas April 5, 2021
Analysis: Zantac May Form High Levels of Toxic NDMA in the Body

An analysis published in the Journal of the American Medical Association (JAMA) Network Open, suggests Zantac and drugs containing ranitidine may cause high…

Michelle Llamas March 22, 2021
Adverse Drug Events: What Consumers Need to Know

In 2019, pharmacies filled an estimated 4.38 billion prescriptions. When you pick up your medication, it comes with a paper or booklet containing…

Rachel Brummert March 22, 2021
Elmiron & Vision Problems Lawsuits: A Q&A with Trial Attorney Trent Miracle

Elmiron, or pentosan polysulfate sodium, is the only oral medication approved by the U.S. Food and Drug Administration to treat…

Michelle Llamas September 25, 2020
Rheumatoid Arthritis Drug Methotrexate Linked to Increased Skin Cancer Risk

A double-blind, placebo-controlled, randomized clinical trial funded by the National Institutes of Health linked low-dose methotrexate to an increased risk of skin…

Michelle Llamas June 22, 2020
Chlorthalidone Linked to Higher Risk of Electrolyte, Kidney Problems

Chlorthalidone — known by the brand name Thalitone — is the American College of Cardiology and American Heart Association’s preferred first-line treatment…

Michelle Llamas April 20, 2020

1
2
3
4
5
6
7
8
9
…
16

Drugwatch Archives

Looking for an older news story? Search the Drugwatch archives for any of our published news posts by month and category.

Month

Category

Drugwatch is located at:
1 South Orange Ave, Suite 201, Orlando, FL 32801

The information on this website is proprietary and protected. It is not a substitute for professional medical advice, diagnosis or treatment. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our disclaimer for more information about our website.

Drugwatch.com partners with law firms. This website and its content may be deemed attorney advertising. Prior results do not predict a similar outcome. For more information, visit our partners page.

© 2021 Drugwatch.com Privacy Policy /